Androgenetic alopecia – also known as male or female pattern hair loss – is the most common form of progressive hair loss, affecting 50% of men over the age of 50 and 50% of women over the age of 65. In men, the hair loss tends to appear as a receding hairline and hair loss from the top and front of the head, while women typically see thinning hair at the crown of the scalp.
Androgenetic alopecia is thought to be genetically and environmentally determined, which is why this condition tends to cluster in families. Researchers have determined that the hormone group, androgens, plays a major role in this form of hair loss, with the main hormone being dihydrotestosterone (DHT). This hormone contributes to the development of hair, meaning it can also contribute to hair loss. With increased levels of dihydrotestosterone, hair growth cycles tend to be shorter and the hair that does grow is shorter and thinner. Over time, the regrowth of hair can stop, leading to patches of hair loss.
Treatment options for androgenetic alopecia include topical solutions such as minoxidil solution in 2% or 5% strength, applied directly to the scalp. This treatment may slow down the progression of hair loss and has the potential to partially restore some hair in small patches. However, this treatment is not a long-term solution as this product only works for as long as the hair loss sufferer applies it. It can also become very expensive over time.
There are various surgical options for hair loss available, such as a hair transplant or a scalp reduction, but both are extremely invasive, causing extreme swelling and discomfort, and require considerable downtime and recovery following surgery.
Backed by two patents and fifteen years of Italian innovation and dermatology experience, TRICOPAT™ represents a pain-free treatment for hair loss that is unparalleled in the Australian trichology market.
TRICOPAT™ utilises the TRICOGENESI methodology of Skin Patting to stimulate the hair follicle and effectively treat hair loss and scalp concerns. This industry-first technique combines the safety of controlled micro-incision and the efficacy of radial pressure waves to achieve significant improvement in androgenic alopecia symptoms.
TRICOPAT™ results in proven, long-lasting hair restoration. A six-month study showed that out of ten male and ten female patients suffering from AGA that underwent the TRICOPAT™ treatment protocol, all 20 patients saw improvements and finished the study without any reactions or side effects.
TRICOPAT™ offers clinics offering trichology treatments a new, effective solution to hair loss that far surpasses the results of competitor treatments in the market.To learn more about TRICOPAT™ treatment for androgenetic alopecia and how it can benefit your clinic, contact us or visit our website to download our complimentary brochure.